InsidersTradesSigma
Explore the full record of transactions filed by Fitzgerald Thomas A, Chief Financial Officer. Insider active across 1 companies, notably Transcode Therapeutics, Inc.. In total, 1 reports have been logged. Total volume traded: €14k. The latest transaction was disclosed on 16 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Thomas A. Fitzgerald is the Chief Financial Officer of Transcode Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is crucial in ensuring the financial stability of Transcode Therapeutics and supporting its growth. With his expertise, he contributes to informed decision-making for the company's future.